{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T22:48:27Z","timestamp":1788648507267,"version":"build-2803163510"},"reference-count":69,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hematology\/Oncology Clinics of North America"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.hoc.2021.05.005","type":"journal-article","created":{"date-parts":[[2021,7,14]],"date-time":"2021-07-14T00:43:05Z","timestamp":1626223385000},"page":"933-947","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Cancer of the Larynx and Hypopharynx"],"prefix":"10.1016","volume":"35","author":[{"given":"Kristen A.","family":"Echanique","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauran K.","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert Y.","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinesh K.","family":"Chhetri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maie A.","family":"St. John","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.hoc.2021.05.005_bib1","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1200\/JCO.2012.43.6097","article-title":"Long-term results of RTOG 91-11: a comparison of three nonsurgical treatment strategies to preserve the larynx in patients with locally advanced larynx cancer","volume":"31","author":"Forastiere","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"issue":"24","key":"10.1016\/j.hoc.2021.05.005_bib2","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJM199106133242402","article-title":"Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer","volume":"324","author":"Department of Veterans Affairs Laryngeal Cancer Study Group","year":"1991","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.hoc.2021.05.005_bib3","doi-asserted-by":"crossref","first-page":"xvii","DOI":"10.1016\/j.otc.2017.06.002","article-title":"Multidisciplinary Approach to Head and Neck Cancer","volume":"50","author":"St John","year":"2017","journal-title":"Otolaryngol Clin North Am"},{"key":"10.1016\/j.hoc.2021.05.005_bib4","author":"American Cancer Society"},{"issue":"6","key":"10.1016\/j.hoc.2021.05.005_bib5","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1097\/MLG.0b013e3181671b3d","article-title":"Staging and survival analysis for nonsquamous cell carcinomas of the larynx","volume":"118","author":"Lin","year":"2008","journal-title":"Laryngoscope"},{"key":"10.1016\/j.hoc.2021.05.005_bib6","series-title":"Centers for Disease Control National Program of Cancer Registries SEER\u2217Stat Database: U.S. Cancer Statistics Incidence Analytic File 1998\u20132015","author":"United States Department of Health and Human Services, Centers for Disease Control and Prevention","year":"2018"},{"key":"10.1016\/j.hoc.2021.05.005_bib7","series-title":"Bailey\u2019s head and neck surgery: otolaryngology","first-page":"1940","article-title":"Chapter 123: Early laryngeal cancer","year":"2013"},{"key":"10.1016\/j.hoc.2021.05.005_bib8","article-title":"European Laryngological Society position paper on laryngeal dysplasia Part I: aetiology and pathological classification","author":"Odell","year":"2020","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"10.1016\/j.hoc.2021.05.005_bib9","article-title":"Prognostic significance of HPV status in laryngeal squamous cell carcinoma: a large-population database study","author":"Panuganti","year":"2020","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"11","key":"10.1016\/j.hoc.2021.05.005_bib10","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20200216","article-title":"Presence of pepsin in laryngeal tissue and saliva in benign and malignant neoplasms","volume":"40","author":"Zub\u010di\u0107","year":"2020","journal-title":"Biosci Rep"},{"key":"10.1016\/j.hoc.2021.05.005_bib11","series-title":"Bailey\u2019s head and neck surgery: otolaryngology","first-page":"1917","article-title":"Chapter 122: Hypopharyngeal and cervical esophageal carcinoma","year":"2013"},{"key":"10.1016\/j.hoc.2021.05.005_bib12","article-title":"Disparities in mortality from larynx cancer: implications for reducing racial differences","author":"Chen","year":"2020","journal-title":"Laryngoscope"},{"issue":"7","key":"10.1016\/j.hoc.2021.05.005_bib13","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1002\/lary.25212","article-title":"Racial disparities in laryngeal cancer treatment and outcome: a population-based analysis of 24,069 patients","volume":"125","author":"Shin","year":"2015","journal-title":"Laryngoscope"},{"key":"10.1016\/j.hoc.2021.05.005_bib14","article-title":"Proteomic analysis of hypopharyngeal and laryngeal squamous cell carcinoma sheds light on differences in survival","volume":"10","author":"Liu","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.hoc.2021.05.005_bib15","series-title":"Principles of deglutition: a multidisciplinary text for swallowing and its disorders","first-page":"175","article-title":"Development, anatomy, and physiology of the larynx","author":"Wadie","year":"2013"},{"issue":"1","key":"10.1016\/j.hoc.2021.05.005_bib16","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/s00276-002-0015-8","article-title":"Topographical analysis of lymphatic pathways from the meso- and hypopharynx based on minute cadaveric dissections: possible application to neck dissection in pharyngeal cancer surgery","volume":"24","author":"Saito","year":"2002","journal-title":"Surg Radiol Anat SRA"},{"issue":"5","key":"10.1016\/j.hoc.2021.05.005_bib18","first-page":"689","article-title":"Association of laryngeal cancer with vocal cord leukoplakia and associated risk factors in 1,184 patients diagnosed in otorhinolaryngology practices in Germany","volume":"8","author":"Kostev","year":"2018","journal-title":"Mol Clin Oncol"},{"issue":"1","key":"10.1016\/j.hoc.2021.05.005_bib19","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1177\/000348940811700114","article-title":"Institutional and comprehensive review of laryngeal leukoplakia","volume":"117","author":"Isenberg","year":"2008","journal-title":"Ann Otol Rhinol Laryngol"},{"issue":"11","key":"10.1016\/j.hoc.2021.05.005_bib20","doi-asserted-by":"crossref","first-page":"3427","DOI":"10.1002\/hed.26428","article-title":"Utility of narrowband imaging in the diagnosis of laryngeal leukoplakia: Systematic review and meta-analysis","volume":"42","author":"Ahmadzada","year":"2020","journal-title":"Head Neck"},{"issue":"1","key":"10.1016\/j.hoc.2021.05.005_bib21","doi-asserted-by":"crossref","first-page":"11110","DOI":"10.1038\/s41598-017-11709-9","article-title":"A\u00a0novel role for Nanog as an early cancer risk marker in patients with laryngeal precancerous lesions","volume":"7","author":"Rodrigo","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.hoc.2021.05.005_bib22","article-title":"Biomarkers for malignant potential in vocal fold leukoplakia: a state of the art review","author":"Wan","year":"2020","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"22","key":"10.1016\/j.hoc.2021.05.005_bib23","doi-asserted-by":"crossref","first-page":"e7033","DOI":"10.1097\/MD.0000000000007033","article-title":"Clinicopathological parameters associated with histological background and recurrence after surgical intervention of vocal cord leukoplakia","volume":"96","author":"Cui","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.hoc.2021.05.005_bib24","article-title":"Laryngeal Leukoplakia: State of the Art Review","author":"Park","year":"2020","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"4","key":"10.1016\/j.hoc.2021.05.005_bib25","doi-asserted-by":"crossref","first-page":"289","DOI":"10.14639\/0392-100X-807","article-title":"Malignant salivary gland tumours of the larynx: a single institution review","volume":"36","author":"Karatayli-Ozgursoy","year":"2016","journal-title":"Acta Otorhinolaryngol Ital"},{"issue":"7","key":"10.1016\/j.hoc.2021.05.005_bib26","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1002\/lary.20888","article-title":"Management of laryngeal premalignant lesions in the Netherlands","volume":"120","author":"Fleskens","year":"2010","journal-title":"Laryngoscope"},{"issue":"5","key":"10.1016\/j.hoc.2021.05.005_bib27","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/0092-8674(90)90186-I","article-title":"A\u00a0genetic model for colorectal tumorigenesis","volume":"61","author":"Fearon","year":"1990","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.hoc.2021.05.005_bib28","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1002\/1097-0142(195309)6:5<963::AID-CNCR2820060515>3.0.CO;2-Q","article-title":"Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin","volume":"6","author":"Slaughter","year":"1953","journal-title":"Cancer"},{"issue":"11","key":"10.1016\/j.hoc.2021.05.005_bib29","first-page":"2488","article-title":"Genetic progression model for head and neck cancer: implications for field cancerization","volume":"56","author":"Califano","year":"1996","journal-title":"Cancer Res"},{"issue":"20","key":"10.1016\/j.hoc.2021.05.005_bib30","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1056\/NEJMra021902","article-title":"Rules for making human tumor cells","volume":"347","author":"Hahn","year":"2002","journal-title":"N\u00a0Engl J Med"},{"issue":"19","key":"10.1016\/j.hoc.2021.05.005_bib31","first-page":"4477","article-title":"The incidence of p53 mutations increases with progression of head and neck cancer","volume":"53","author":"Boyle","year":"1993","journal-title":"Cancer Res"},{"issue":"5157","key":"10.1016\/j.hoc.2021.05.005_bib32","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1126\/science.8153634","article-title":"A\u00a0cell cycle regulator potentially involved in genesis of many tumor types","volume":"264","author":"Kamb","year":"1994","journal-title":"Science"},{"issue":"21","key":"10.1016\/j.hoc.2021.05.005_bib33","doi-asserted-by":"crossref","first-page":"6257","DOI":"10.1158\/1078-0432.CCR-07-1247","article-title":"Amplicon mapping and expression profiling identify the Fas-associated death domain gene as a new driver in the 11q13.3 amplicon in laryngeal\/pharyngeal cancer","volume":"13","author":"Gibcus","year":"2007","journal-title":"Clin Cancer Res"},{"issue":"13","key":"10.1016\/j.hoc.2021.05.005_bib34","doi-asserted-by":"crossref","first-page":"2980","DOI":"10.1200\/JCO.2002.06.161","article-title":"Alteration of p53 pathway in squamous cell carcinoma of the head and neck: impact on treatment outcome in patients treated with larynx preservation intent","volume":"20","author":"Osman","year":"2002","journal-title":"J\u00a0Clin Oncol"},{"issue":"3","key":"10.1016\/j.hoc.2021.05.005_bib35","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/0092-8674(93)90384-3","article-title":"The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53","volume":"75","author":"Scheffner","year":"1993","journal-title":"Cell."},{"issue":"4","key":"10.1016\/j.hoc.2021.05.005_bib36","first-page":"233","article-title":"Molecular classification of nodal metastasis in primary larynx squamous cell carcinoma","volume":"150","author":"Carinci","year":"2007","journal-title":"Transl Res J Lab Clin Med"},{"issue":"1","key":"10.1016\/j.hoc.2021.05.005_bib37","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.canlet.2011.03.013","article-title":"A\u00a0prognostic multigene classifier for squamous cell carcinomas of the larynx","volume":"307","author":"Mirisola","year":"2011","journal-title":"Cancer Lett"},{"issue":"27","key":"10.1016\/j.hoc.2021.05.005_bib38","doi-asserted-by":"crossref","first-page":"23297","DOI":"10.18632\/oncotarget.4195","article-title":"The role of microRNAs expression in laryngeal cancer","volume":"6","author":"Yu","year":"2015","journal-title":"Oncotarget"},{"issue":"9\u201310","key":"10.1016\/j.hoc.2021.05.005_bib39","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.cancergen.2013.09.005","article-title":"Identification of predictive biomarkers for early diagnosis of larynx carcinoma based on microRNA expression data","volume":"206","author":"Wang","year":"2013","journal-title":"Cancer Genet"},{"issue":"2","key":"10.1016\/j.hoc.2021.05.005_bib40","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/hed.23890","article-title":"Role of miR-145 in human laryngeal squamous cell carcinoma","volume":"38","author":"Karatas","year":"2016","journal-title":"Head Neck"},{"issue":"1","key":"10.1016\/j.hoc.2021.05.005_bib41","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1080\/14737159.2020.1699062","article-title":"Detection, prediction, and prognosis: blood circulating microRNA as novel molecular markers of head and neck cancer patients","volume":"20","author":"Powr\u00f3zek","year":"2020","journal-title":"Expert Rev Mol Diagn"},{"issue":"8","key":"10.1016\/j.hoc.2021.05.005_bib42","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1002\/hed.23413","article-title":"Promoter hypermethylation of CDKN2A, MGMT, MLH1, and DAPK genes in laryngeal squamous cell carcinoma and their associations with clinical profiles of the patients","volume":"36","author":"Pierini","year":"2014","journal-title":"Head Neck"},{"issue":"22","key":"10.1016\/j.hoc.2021.05.005_bib43","first-page":"6686","article-title":"Clinical analysis of EBRT vs TLM in the treatment of early (T1-T2N0) glottic laryngeal cancer","volume":"11","author":"Shen","year":"2020","journal-title":"J\u00a0Cancer"},{"key":"10.1016\/j.hoc.2021.05.005_bib44","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.2147\/OTT.S137210","article-title":"The voice quality after laser surgery versus radiotherapy of T1a glottic carcinoma: systematic review and meta-analysis","volume":"10","author":"Huang","year":"2017","journal-title":"Oncotargets Ther"},{"issue":"2","key":"10.1016\/j.hoc.2021.05.005_bib45","first-page":"210","article-title":"Total laryngectomy \u2013 past, present, future","volume":"9","author":"Ceachir","year":"2014","journal-title":"M\u00e6dica"},{"issue":"6","key":"10.1016\/j.hoc.2021.05.005_bib46","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1001\/archotol.133.6.526","article-title":"Life after total laryngectomy: a measure of long-term survival, function, and quality of life","volume":"133","author":"Woodard","year":"2007","journal-title":"Arch Otolaryngol Head Neck Surg"},{"issue":"10","key":"10.1016\/j.hoc.2021.05.005_bib47","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1002\/cncr.30483","article-title":"Complications, hospital length of stay, and readmission after total laryngectomy","volume":"123","author":"Goepfert","year":"2017","journal-title":"Cancer"},{"issue":"9","key":"10.1016\/j.hoc.2021.05.005_bib48","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1002\/lary.28343","article-title":"Primary laryngectomy versus salvage laryngectomy: a comparison of outcomes in the chemoradiation era","volume":"130","author":"Sullivan","year":"2020","journal-title":"Laryngoscope"},{"issue":"22","key":"10.1016\/j.hoc.2021.05.005_bib49","doi-asserted-by":"crossref","first-page":"4905","DOI":"10.1002\/cncr.33185","article-title":"Association between postoperative complications and long-term oncologic outcomes following total laryngectomy: 10-year experience at MD Anderson Cancer Center","volume":"126","author":"Boukovalas","year":"2020","journal-title":"Cancer"},{"key":"10.1016\/j.hoc.2021.05.005_bib50","first-page":"10","article-title":"A\u00a010-year study on larynx preservation compared with surgical resection in patients with locally advanced laryngeal and hypopharyngeal cancers","author":"Su","year":"2020","journal-title":"Front Oncol"},{"issue":"4","key":"10.1016\/j.hoc.2021.05.005_bib51","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.otc.2017.03.013","article-title":"Systemic treatment for squamous cell carcinoma of the head and neck","volume":"50","author":"Shetty","year":"2017","journal-title":"Otolaryngol Clin North Am"},{"issue":"1","key":"10.1016\/j.hoc.2021.05.005_bib52","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S0360-3016(03)00511-X","article-title":"The epidermal growth factor receptor mediates radioresistance","volume":"57","author":"Liang","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"16","key":"10.1016\/j.hoc.2021.05.005_bib53","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1200\/JCO.2006.06.6605","article-title":"Epidermal growth factor receptor copy number alterations correlate with poor clinical outcome in patients with head and neck squamous cancer","volume":"25","author":"Temam","year":"2007","journal-title":"J\u00a0Clin Oncol"},{"issue":"17","key":"10.1016\/j.hoc.2021.05.005_bib54","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1200\/JCO.2005.04.8306","article-title":"Epidermal growth factor receptor biology in head and neck cancer","volume":"24","author":"Kalyankrishna","year":"2006","journal-title":"J\u00a0Clin Oncol"},{"issue":"6","key":"10.1016\/j.hoc.2021.05.005_bib55","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1056\/NEJMoa053422","article-title":"Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck","volume":"354","author":"Bonner","year":"2006","journal-title":"N\u00a0Engl J Med"},{"issue":"11","key":"10.1016\/j.hoc.2021.05.005_bib56","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1056\/NEJMoa0802656","article-title":"Platinum-based chemotherapy plus cetuximab in head and neck cancer","volume":"359","author":"Vermorken","year":"2008","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.hoc.2021.05.005_bib57","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s40644-020-00359-2","article-title":"CT-based radiomics features in the prediction of thyroid cartilage invasion from laryngeal and hypopharyngeal squamous cell carcinoma","volume":"20","author":"Guo","year":"2020","journal-title":"Cancer Imaging"},{"issue":"1","key":"10.1016\/j.hoc.2021.05.005_bib58","doi-asserted-by":"crossref","first-page":"18327","DOI":"10.1038\/s41598-020-73747-0","article-title":"A\u00a0role for the immune system in advanced laryngeal cancer","volume":"10","author":"Tagliabue","year":"2020","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.hoc.2021.05.005_bib59","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s00262-018-2256-3","article-title":"Analysis of tumor-infiltrating CD103 resident memory T-cell content in recurrent laryngeal squamous cell carcinoma","volume":"68","author":"Mann","year":"2019","journal-title":"Cancer Immunol Immunother CII"},{"key":"10.1016\/j.hoc.2021.05.005_bib60","doi-asserted-by":"crossref","first-page":"9013","DOI":"10.2147\/CMAR.S275635","article-title":"The clinical impacts of pretreatment peripheral blood ratio on lymphocytes, monocytes, and neutrophils among patients with laryngeal\/hypopharyngeal cancer treated by chemoradiation\/radiation","volume":"12","author":"Chuang","year":"2020","journal-title":"Cancer Manag Res"},{"issue":"11","key":"10.1016\/j.hoc.2021.05.005_bib61","article-title":"Identification of prognostic immune genes in laryngeal cancer","volume":"48","author":"Xiao","year":"2020","journal-title":"J\u00a0Int Med Res"},{"key":"10.1016\/j.hoc.2021.05.005_bib62","doi-asserted-by":"crossref","first-page":"295","DOI":"10.2147\/TCRM.S125059","article-title":"New developments in the management of head and neck cancer \u2013 impact of pembrolizumab","volume":"14","author":"Saleh","year":"2018","journal-title":"Ther Clin Risk Manag"},{"key":"10.1016\/j.hoc.2021.05.005_bib63","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.oraloncology.2018.04.008","article-title":"Nivolumab vs investigator\u2019s choice in recurrent or metastatic squamous cell carcinoma of the head and neck: 2-year long-term survival update of CheckMate 141 with analyses by tumor PD-L1 expression","volume":"81","author":"Ferris","year":"2018","journal-title":"Oral Oncol"},{"issue":"7","key":"10.1016\/j.hoc.2021.05.005_bib64","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/S1470-2045(16)30066-3","article-title":"Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): an open-label, multicentre, phase 1b trial","volume":"17","author":"Seiwert","year":"2016","journal-title":"Lancet Oncol"},{"issue":"2","key":"10.1016\/j.hoc.2021.05.005_bib65","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1002\/hed.25444","article-title":"Mutational profiles of persistent\/recurrent laryngeal squamous cell carcinoma","volume":"41","author":"Smith","year":"2019","journal-title":"Head Neck"},{"key":"10.1016\/j.hoc.2021.05.005_bib66","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.oraloncology.2017.12.003","article-title":"Proportion of CD4 and CD8 tumor infiltrating lymphocytes predicts survival in persistent\/recurrent laryngeal squamous cell carcinoma","volume":"77","author":"Hoesli","year":"2018","journal-title":"Oral Oncol"},{"key":"10.1016\/j.hoc.2021.05.005_bib67","article-title":"Development and validation of a novel metabolic signature for predicting prognosis in patients with laryngeal cancer","author":"Li","year":"2020","journal-title":"Eur Arch Oto-rhino-laryngol"},{"key":"10.1016\/j.hoc.2021.05.005_bib68","article-title":"Comparative effectiveness of posttreatment imaging modalities for Medicare patients with advanced head and neck cancer","author":"Morgan","year":"2020","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.hoc.2021.05.005_bib69","doi-asserted-by":"crossref","first-page":"479","DOI":"10.6004\/jnccn.2018.0026","article-title":"NCCN guidelines insights: head and neck cancers, version 1.2018","volume":"16","author":"Colevas","year":"2018","journal-title":"J\u00a0Natl Compr Cancer Netw JNCCN"},{"issue":"3","key":"10.1016\/j.hoc.2021.05.005_bib70","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1002\/lary.26268","article-title":"When should surveillance imaging be performed after treatment for head and neck cancer?","volume":"127","author":"Heineman","year":"2017","journal-title":"Laryngoscope"}],"container-title":["Hematology\/Oncology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889858821000617?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889858821000617?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T12:15:16Z","timestamp":1760184916000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889858821000617"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":69,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["S0889858821000617"],"URL":"https:\/\/doi.org\/10.1016\/j.hoc.2021.05.005","relation":{},"ISSN":["0889-8588"],"issn-type":[{"value":"0889-8588","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cancer of the Larynx and Hypopharynx","name":"articletitle","label":"Article Title"},{"value":"Hematology\/Oncology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hoc.2021.05.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}